Earnings calendar
US companies reporting quarterly results in the week of Aug 14 – Aug 18, 2023. Reported figures come from each company's earnings release filed with the SEC; expected dates are estimated from when the company reported in past years.
259 companies · 259 reported
Monday, August 14, 2023
160 companies, largest first · 46 before the open, 73 after the close
| Company | Time | Quarter | Market cap | Revenue | Year ago | Growth | EPS | Year ago | Status |
|---|---|---|---|---|---|---|---|---|---|
| Before open | Q1 FY2023 | $27.61B | $21.62M | $4.32M | +400.7% | -$0.38 | -$0.48 | Release ↗ | |
| During market | Q2 FY2023 | $6.19B | – | – | – | -$1.53 | -$1.74 | Release ↗ | |
| Before open | Q2 FY2023 | $5.84B | $15.50M | – | – | -$0.08 | – | Release ↗ | |
| After close | Q2 FY2023 | $3.92B | $70.80M | $48.84M | +45.0% | -$0.07 | -$0.53 | Release ↗ | |
| During market | Q2 FY2023 | $3.39B | $98.50M | $97.20M | +1.3% | $0.25 | – | Release ↗ | |
| After close | Q2 FY2023 | $2.53B | $25.00M | $4.40M | +468.3% | -$0.15 | -$0.57 | Release ↗ | |
| After close | Q2 FY2023 | $2.44B | $61.50M | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $2.27B | $18.00M | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $2.11B | $18.10M | $8.60M | +110.5% | -$0.05 | -$0.07 | Release ↗ | |
| Before open | Q2 FY2023 | $1.98B | $793.00M | – | – | $0.52 | – | Release ↗ | |
| Before open | Q2 FY2023 | $1.80B | $3.40M | $1.00M | +239.3% | -$0.45 | -$0.32 | Release ↗ | |
| After close | Q2 FY2023 | $1.78B | $62.85M | $59.64M | +5.4% | -$2.11 | -$1.34 | Release ↗ | |
| Before open | Q2 FY2023 | $1.42B | $2.40M | – | – | -$0.38 | -$0.84 | Release ↗ | |
| After close | Q3 FY2023 | $959.80M | $114.70M | $134.40M | −14.7% | -$0.67 | -$0.20 | Release ↗ | |
| Before open | Q2 FY2023 | $956.50M | – | – | – | – | -$0.49 | Release ↗ | |
| During market | Q2 FY2023 | $915.01M | $121.90M | $120.50M | +1.2% | $0.28 | $0.10 | Release ↗ | |
| Before open | Q2 FY2023 | $885.02M | $18.30M | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $779.32M | $200.00K | $5.90M | −96.6% | -$1.12 | -$1.01 | Release ↗ | |
| After close | Q2 FY2023 | $718.26M | – | – | – | -$0.43 | -$1.08 | Release ↗ | |
| During market | Q2 FY2023 | $665.24M | – | – | – | -$0.36 | -$0.27 | Release ↗ | |
| Before open | Q2 FY2023 | $663.32M | $8.50M | $1.30M | +553.8% | -$0.15 | -$0.70 | Release ↗ | |
| During market | Q2 FY2023 | $580.78M | – | – | – | -$0.16 | -$0.13 | Release ↗ | |
| Before open | Q2 FY2023 | $495.10M | – | – | – | – | 1.64 CNY | Release ↗ | |
| During market | Q3 FY2023 | $474.84M | $10.10M | $10.60M | −4.7% | -$0.05 | -$0.04 | Release ↗ | |
| indpIndaptus Therapeutics | Before open | Q2 FY2023 | $439.70M | – | – | – | -$0.39 | -$0.46 | Release ↗ |
| During market | Q2 FY2023 | $385.23M | – | – | – | -$1.31 | – | Release ↗ | |
| During market | Q2 FY2023 | $373.41M | $27.00M | – | – | $0.04 | – | Release ↗ | |
| Before open | Q2 FY2023 | $349.95M | – | – | – | -$0.15 | -$0.16 | Release ↗ | |
| Before open | Q2 FY2023 | $309.28M | – | – | – | -$0.91 | -$0.15 | Release ↗ | |
| After close | Q2 FY2023 | $297.05M | $15.80M | $9.70M | +62.9% | -$0.22 | – | Release ↗ | |
| During market | Q1 FY2024 | $279.78M | $137.30M | $75.09M | +82.8% | $1.04 | -$1.11 | Release ↗ | |
| During market | Q1 FY2024 | $270.10M | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $201.22M | $10.90M | $9.55M | +14.1% | $0.04 | $0.04 | Release ↗ | |
| After close | Q2 FY2023 | $193.30M | $14.50M | $6.40M | +126.6% | $0.01 | $0.04 | Release ↗ | |
| Before open | Q2 FY2023 | $186.16M | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $184.97M | $13.80M | – | – | -$0.01 | – | Release ↗ | |
| After close | Q3 FY2023 | $162.89M | $85.50M | $51.20M | +67.0% | $0.21 | $0.10 | Release ↗ | |
| During market | Q2 FY2023 | $157.84M | $14.10M | $22.30M | −36.8% | -$0.19 | -$0.30 | Release ↗ | |
| After close | Q2 FY2023 | $151.30M | $2.90M | $4.50M | −35.6% | -$0.12 | $0.00 | Release ↗ | |
| Before open | Q2 FY2023 | $141.69M | – | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $133.96M | $2.20M | – | – | -$0.32 | -$0.51 | Release ↗ | |
| After close | Q2 FY2023 | $131.30M | $61.00M | $54.50M | +11.9% | $0.08 | $0.06 | Release ↗ | |
| Before open | Q2 FY2023 | $125.01M | – | $1.30M | – | -$0.22 | $0.35 | Release ↗ | |
| Before open | Q2 FY2023 | $116.75M | $1.00M | $1.90M | −47.4% | -$0.17 | -$0.26 | Release ↗ | |
| After close | Q2 FY2023 | $114.46M | $1.98M | $16.20M | −87.8% | -$0.01 | -$0.04 | Release ↗ | |
| After close | Q3 FY2023 | $112.50M | – | – | – | -$0.08 | -$0.08 | Release ↗ | |
| After close | Q2 FY2023 | $111.37M | $335.00M | $425.50M | −21.3% | -$6.28 | -$0.38 | Release ↗ | |
| After close | Q2 FY2023 | $107.15M | $82.10M | $98.40M | −16.6% | $0.01 | $0.01 | Release ↗ | |
| After close | Q2 FY2023 | $106.16M | – | – | – | -$0.14 | $0.32 | Release ↗ | |
| srgSeritage Growth Properties | After close | Q2 FY2023 | $99.13M | $5.88M | $29.70M | −80.2% | -$1.73 | -$2.56 | Release ↗ |
| After close | Q2 FY2023 | $99.08M | – | – | – | – | – | Reported | |
| During market | Q2 FY2023 | $85.49M | $21.30M | – | – | $0.01 | – | Release ↗ | |
| During market | Q2 FY2023 | $84.11M | $27.15M | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $79.57M | $3.38M | $1.53M | +120.5% | -$0.15 | -$0.33 | Release ↗ | |
| During market | Q2 FY2023 | $78.41M | $6.10M | $5.30M | +15.1% | $0.09 | $0.04 | Release ↗ | |
| During market | Q2 FY2023 | $76.82M | $14.80M | – | – | $0.40 | – | Release ↗ | |
| Before open | Q2 FY2023 | $75.59M | $8.00M | $13.50M | −40.7% | -$0.10 | $0.00 | Release ↗ | |
| After close | Q2 FY2023 | $72.76M | – | – | – | -$0.37 | – | Release ↗ | |
| After close | Q2 FY2023 | $72.45M | $17.40M | $18.90M | −7.9% | -$0.07 | -$0.10 | Release ↗ | |
| Before open | Q2 FY2023 | $70.74M | $50.80M | $50.00M | +1.6% | $0.07 | -$0.13 | Release ↗ | |
| After close | Q2 FY2023 | $66.31M | – | – | – | -$0.57 | -$0.36 | Release ↗ | |
| Before open | Q4 FY2023 | $62.80M | $10.00M | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $56.69M | $31.76M | $27.60M | +15.1% | -$0.35 | -$0.55 | Release ↗ | |
| During market | Q2 FY2023 | $54.47M | $1.71M | $50.00K | +3310.0% | -$0.20 | -$0.28 | Release ↗ | |
| After close | Q2 FY2023 | $52.92M | $37.90M | – | – | $0.05 | – | Release ↗ | |
| Before open | Q2 FY2023 | $52.68M | $269.00K | $35.00K | +668.6% | -$0.29 | -$0.07 | Release ↗ | |
| Before open | Q2 FY2023 | $50.37M | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $49.43M | $172.00K | – | – | -$2.36 | – | Release ↗ | |
| After close | Q2 FY2023 | $49.33M | $8.60M | $4.33M | +98.4% | -$0.18 | -$0.33 | Release ↗ | |
| Before open | Q2 FY2023 | $47.41M | – | – | – | – | -$0.40 | Release ↗ | |
| After close | Q2 FY2023 | $47.40M | $66.10M | $79.30M | −16.6% | -$0.32 | -$1.06 | Release ↗ | |
| After close | Q2 FY2023 | $46.44M | $12.50M | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $45.00M | – | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $43.80M | $58.80M | $65.10M | −9.7% | -$0.88 | -$1.22 | Release ↗ | |
| After close | Q2 FY2023 | $42.93M | $9.00K | – | – | -$0.07 | – | Release ↗ | |
| After close | Q2 FY2023 | $40.83M | $256.90M | – | – | -$0.76 | – | Release ↗ | |
| After close | Q2 FY2023 | $40.75M | $10.70M | $12.60M | −15.1% | -$0.07 | $0.00 | Release ↗ | |
| yarwYarrow Bioscience | Before open | Q2 FY2023 | $39.81M | $100.00K | $100.00K | 0.0% | -$2.82 | -$0.13 | Release ↗ |
| After close | Q2 FY2023 | $39.09M | $1.17M | $561.00K | +108.6% | -$0.13 | -$0.19 | Release ↗ | |
| rdiReading International | During market | Q2 FY2023 | $38.34M | $65.10M | $64.50M | +0.9% | -$0.12 | -$0.11 | Release ↗ |
| After close | Q1 FY2024 | $37.80M | $13.00M | $13.60M | −4.4% | -$0.37 | -$0.03 | Release ↗ | |
| After close | Q2 FY2023 | $37.65M | $2.10M | $4.70M | −55.3% | -$0.18 | -$0.07 | Release ↗ | |
| During market | Q2 FY2023 | $36.58M | $283.00K | – | – | -$0.02 | -$0.06 | Release ↗ | |
| During market | Q2 FY2023 | $33.64M | $10.30M | $12.60M | −18.3% | -$0.65 | -$0.69 | Release ↗ | |
| Before open | Q2 FY2023 | $32.45M | $18.10M | $18.70M | −3.2% | -$0.18 | – | Release ↗ | |
| After close | Q2 FY2023 | $31.57M | – | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $30.51M | $10.30M | $8.60M | +19.8% | $0.09 | $0.00 | Release ↗ | |
| During market | Q2 FY2023 | $28.60M | – | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $26.76M | $5.10M | – | – | -$0.16 | – | Release ↗ | |
| During market | Q2 FY2023 | $26.64M | $12.10M | $4.30M | +181.4% | $0.05 | -$0.26 | Release ↗ | |
| After close | Q2 FY2023 | $23.74M | $20.00K | – | – | -$0.20 | – | Release ↗ | |
| After close | Q2 FY2023 | $23.70M | $1.84M | $2.20M | −16.1% | -$0.14 | -$0.04 | Release ↗ | |
| After close | Q2 FY2023 | $22.79M | $2.80M | $5.10M | −45.1% | -$1.96 | -$0.12 | Release ↗ | |
| After close | Q2 FY2023 | $22.25M | $74.50M | $76.90M | −3.1% | $0.07 | $0.19 | Release ↗ | |
| During market | Q2 FY2023 | $21.84M | $3.00M | – | – | – | – | Release ↗ | |
| After close | Q3 FY2023 | $21.19M | $38.20M | $41.10M | −7.1% | $0.07 | $0.02 | Release ↗ | |
| Before open | Q2 FY2023 | $21.16M | – | – | – | -$0.08 | -$0.05 | Release ↗ | |
| Before open | Q2 FY2023 | $21.07M | $400.00K | $28.60M | −98.6% | -$0.24 | $12.39 | Release ↗ | |
| vipVulcan Infrastructure & Power | After close | Q2 FY2023 | $20.83M | $14.70M | $31.30M | −53.0% | – | -$2.61 | Release ↗ |
| During market | Q2 FY2023 | $18.72M | $9.90M | – | – | -$0.11 | – | Release ↗ |
Showing the 100 largest; 60 smaller ones are not listed.
Tuesday, August 15, 2023
44 companies, largest first · 17 before the open, 16 after the close
| Company | Time | Quarter | Market cap | Revenue | Year ago | Growth | EPS | Year ago | Status |
|---|---|---|---|---|---|---|---|---|---|
| Before open | Q2 FY2023 | $354.62B | $42.90B | $43.80B | −2.1% | $4.65 | $5.05 | Release ↗ | |
| Before open | Q4 FY2023 | $60.92B | $53.50B | $47.10B | +13.6% | $1.55 | $1.05 | Release ↗ | |
| During market | Q3 FY2023 | $49.95B | $1.67B | $1.72B | −2.9% | $1.43 | $1.34 | Release ↗ | |
| During market | Q2 FY2023 | $37.68B | $2.40B | – | – | $0.69 | – | Release ↗ | |
| After close | Q4 FY2023 | $12.56B | $534.63M | $482.67M | +10.8% | $1.34 | $1.10 | Release ↗ | |
| Before open | Q2 FY2023 | $10.84B | CHF 444.30M | – | – | 0.01 CHF | – | Release ↗ | |
| During market | Q2 FY2023 | $7.24B | $172.89M | – | – | $0.21 | – | Release ↗ | |
| After close | Q4 FY2023 | $6.84B | $1.03B | – | – | $2.05 | – | Release ↗ | |
| After close | Q4 FY2023 | $4.32B | $253.20M | $289.70M | −12.6% | $0.11 | $0.81 | Release ↗ | |
| Before open | Q2 FY2023 | $4.21B | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $3.62B | $593.90M | $588.20M | +1.0% | $0.24 | $0.42 | Release ↗ | |
| After close | Q4 FY2023 | $3.29B | $483.50M | $455.20M | +6.2% | $1.01 | $0.66 | Release ↗ | |
| Before open | Q2 FY2023 | $2.85B | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $1.04B | – | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $788.39M | – | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $672.52M | $48.50M | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $339.51M | – | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $185.18M | $24.30M | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $177.19M | $1.77M | $3.62M | −51.1% | -$0.42 | -$0.22 | Release ↗ | |
| During market | Q2 FY2023 | $171.86M | $4.80M | – | – | $0.10 | – | Release ↗ | |
| After close | Q2 FY2023 | $104.46M | – | – | – | -$0.29 | -$0.24 | Release ↗ | |
| Before open | Q2 FY2023 | $95.38M | $13.50M | $9.90M | +36.4% | $0.13 | -$0.87 | Release ↗ | |
| After close | Q2 FY2023 | $85.65M | $9.70M | $16.54M | −41.4% | -$0.11 | $0.24 | Release ↗ | |
| Before open | Q2 FY2023 | $44.93M | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $40.04M | $7.53M | – | – | – | – | Release ↗ | |
| Before open | Q3 FY2023 | $30.73M | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $30.19M | $12.36M | $13.21M | −6.4% | $0.01 | – | Release ↗ | |
| Before open | Q2 FY2023 | $29.24M | $35.60M | $29.00M | +22.8% | $0.01 | -$0.03 | Release ↗ | |
| During market | Q2 FY2023 | $27.50M | $24.92M | – | – | -$0.39 | -$0.75 | Release ↗ | |
| kustKustom Entertainment | After close | Q2 FY2023 | $22.64M | $8.28M | $9.35M | −11.5% | -$3.01 | -$0.02 | Release ↗ |
| ffrFF EAI Robotics Ecosystem | During market | Q2 FY2023 | $19.03M | – | $1.40M | – | – | -$0.11 | Release ↗ |
| Before open | Q2 FY2023 | $18.64M | $17.50M | $18.40M | −4.9% | $0.06 | – | Release ↗ | |
| During market | Q3 FY2023 | $16.95M | $51.05M | $53.22M | −4.1% | $0.88 | $1.46 | Release ↗ | |
| During market | Q4 FY2023 | $16.16M | $162.60M | $126.20M | +28.8% | $0.10 | $0.09 | Release ↗ | |
| Before open | Q3 FY2023 | $15.13M | – | – | – | -$0.06 | -$0.06 | Release ↗ | |
| After close | Q2 FY2023 | $8.99M | – | – | – | -$0.25 | – | Release ↗ | |
| After close | Q2 FY2023 | $8.06M | – | $5.00K | – | – | -$0.26 | Reported | |
| After close | Q2 FY2023 | $7.80M | $5.00M | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $5.22M | – | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $3.39M | $1.90M | $1.90M | 0.0% | -$0.16 | -$0.21 | Release ↗ | |
| During market | Q2 FY2023 | $2.62M | $6.80M | $8.50M | −20.0% | – | -$0.18 | Release ↗ | |
| After close | Q1 FY2024 | $2.23M | $100.00K | – | – | -$0.45 | -$0.37 | Release ↗ | |
| During market | Q2 FY2023 | $2.01M | $2.72M | – | – | -$0.06 | – | Release ↗ | |
| Before open | Q2 FY2023 | $1.25M | – | $4.32M | – | – | $0.02 | Release ↗ |
Wednesday, August 16, 2023
26 companies, largest first · 9 before the open, 11 after the close
| Company | Time | Quarter | Market cap | Revenue | Year ago | Growth | EPS | Year ago | Status |
|---|---|---|---|---|---|---|---|---|---|
| After close | Q4 FY2023 | $408.49B | $15.20B | – | – | $1.14 | – | Release ↗ | |
| Before open | Q2 FY2023 | $159.23B | $12.80B | $11.80B | +8.5% | $0.85 | – | Release ↗ | |
| After close | Q3 FY2023 | $88.72B | $1.49B | $1.25B | +19.2% | $2.88 | $2.10 | Release ↗ | |
| Before open | Q2 FY2023 | $74.10B | $24.80B | $26.00B | −4.6% | $1.80 | $0.39 | Release ↗ | |
| After close | Q4 FY2023 | $38.20B | – | $887.00M | – | – | $0.98 | Release ↗ | |
| After close | Q4 FY2023 | $22.42B | $3.67B | $3.91B | −6.0% | $19.30 | $0.07 | Release ↗ | |
| Before open | Q4 FY2023 | $17.26B | $14.90B | $14.60B | +2.1% | $1.14 | $1.07 | Release ↗ | |
| Before open | Q4 FY2023 | $9.21B | $1.08B | $1.02B | +5.3% | $1.39 | $1.15 | Release ↗ | |
| After close | Q4 FY2023 | $7.03B | $6.60B | $6.40B | +3.1% | $2.06 | $2.07 | Release ↗ | |
| After close | Q4 FY2023 | $1.19B | $235.80M | $228.50M | +3.2% | $0.42 | -$0.02 | Release ↗ | |
| During market | Q4 FY2023 | $619.79M | $496.10M | $373.50M | +32.8% | $0.76 | $0.40 | Release ↗ | |
| During market | Q4 FY2023 | $467.02M | – | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $428.03M | $37.40M | – | – | $0.04 | – | Release ↗ | |
| Before open | Q4 FY2023 | $370.74M | $83.90M | $76.00M | +10.4% | $0.62 | $0.58 | Release ↗ | |
| After close | Q2 FY2023 | $211.89M | – | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $80.08M | $10.33M | – | – | $0.07 | – | Release ↗ | |
| During market | Q2 FY2023 | $75.44M | $2.70M | $588.00K | +359.2% | -$0.05 | -$0.05 | Release ↗ | |
| After close | Q2 FY2023 | $74.28M | $28.30M | – | – | – | – | Release ↗ | |
| During market | Q2 FY2023 | $39.42M | $16.50M | $12.50M | +32.0% | $0.11 | $0.12 | Release ↗ | |
| Before open | Q1 FY2023 | $27.33M | $17.10M | $15.70M | +8.9% | $0.04 | $0.14 | Release ↗ | |
| During market | Q2 FY2023 | $19.46M | – | – | – | -$0.41 | -$0.25 | Release ↗ | |
| Before open | Q2 FY2023 | $19.03M | – | – | – | – | – | Release ↗ | |
| After close | Q2 FY2023 | $18.46M | – | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $10.23M | – | $249.04K | – | -$2.75 | -$0.10 | Release ↗ | |
| After close | Q2 FY2023 | $2.24M | $3.40M | – | – | -$0.18 | – | Release ↗ | |
| edvaEndovia Health Sciences | After close | Q2 FY2023 | $138.87K | $5.20M | $4.80M | +8.3% | -$0.13 | – | Release ↗ |
Thursday, August 17, 2023
19 companies, largest first · 12 before the open, 7 after the close
| Company | Time | Quarter | Market cap | Revenue | Year ago | Growth | EPS | Year ago | Status |
|---|---|---|---|---|---|---|---|---|---|
| Before open | Q2 FY2024 | $1.02T | $161.60B | $152.90B | +5.7% | $1.84 | $1.77 | Release ↗ | |
| After close | Q3 FY2023 | $293.15B | $6.43B | $6.52B | −1.4% | $1.90 | $1.94 | Release ↗ | |
| After close | Q2 FY2023 | $78.50B | $4.90B | $4.60B | +6.5% | $1.32 | $1.11 | Release ↗ | |
| Before open | Q4 FY2023 | $56.22B | $370.80M | $422.10M | −12.2% | $0.59 | $1.47 | Release ↗ | |
| After close | Q3 FY2023 | $48.67B | $1.38B | $1.38B | 0.0% | $2.19 | $2.01 | Release ↗ | |
| Before open | Q4 FY2023 | $7.83B | $126.90M | $175.20M | −27.6% | -$0.39 | $1.11 | Release ↗ | |
| After close | Q4 FY2023 | $4.42B | $296.00M | $200.20M | +47.9% | $0.59 | -$0.03 | Release ↗ | |
| After close | Q2 FY2023 | $3.81B | $384.30M | – | – | $2.14 | – | Release ↗ | |
| Before open | Q4 FY2023 | $797.02M | $123.60M | $127.50M | −3.1% | $0.30 | $0.21 | Release ↗ | |
| Before open | Q2 FY2023 | $373.72M | – | – | – | – | $0.24 | Reported | |
| rnacCartesian Therapeutics | Before open | Q2 FY2023 | $193.94M | $5.20M | $39.30M | −86.8% | -$0.07 | $0.06 | Release ↗ |
| After close | Q2 FY2023 | $174.67M | $298.60M | $294.10M | +1.5% | -$0.24 | -$0.75 | Release ↗ | |
| Before open | Q2 FY2023 | $59.12M | – | – | – | -$0.22 | – | Release ↗ | |
| Before open | Q2 FY2023 | $29.83M | $25.97M | – | – | $0.17 | – | Release ↗ | |
| After close | Q2 FY2023 | $24.77M | – | – | – | -$0.21 | – | Release ↗ | |
| Before open | Q2 FY2023 | $5.36M | $345.60M | $380.90M | −9.3% | -$2.12 | -$0.89 | Release ↗ | |
| Before open | Q2 FY2023 | $3.82M | $26.80M | – | – | $0.01 | – | Release ↗ | |
| Before open | Q2 FY2023 | $2.15M | – | – | – | – | – | Release ↗ | |
| Before open | Q1 FY2024 | $995.70K | – | – | – | – | – | Release ↗ |
Friday, August 18, 2023
10 companies, largest first · 4 before the open, 4 after the close
| Company | Time | Quarter | Market cap | Revenue | Year ago | Growth | EPS | Year ago | Status |
|---|---|---|---|---|---|---|---|---|---|
| After close | Q4 FY2023 | $284.70B | $2.00B | $1.60B | +25.0% | $1.44 | $2.39 | Release ↗ | |
| Before open | Q3 FY2023 | $182.40B | $15.80B | $14.10B | +12.0% | $10.20 | $6.16 | Release ↗ | |
| Before open | Q4 FY2023 | $40.54B | $3.61B | $3.56B | +1.4% | – | – | Release ↗ | |
| Before open | Q4 FY2023 | $3.72B | $147.90M | – | – | -$0.47 | – | Release ↗ | |
| During market | Q2 FY2023 | $2.47B | $292.40M | $302.00M | −3.2% | $0.92 | $1.01 | Release ↗ | |
| After close | Q4 FY2023 | $1.14B | $44.70M | $43.20M | +3.5% | – | $0.20 | Release ↗ | |
| After close | Q2 FY2023 | $289.55M | – | $14.00M | – | – | $0.54 | Release ↗ | |
| After close | Q3 FY2023 | $166.51M | – | – | – | -$0.07 | – | Release ↗ | |
| During market | Q2 FY2023 | $67.19M | – | – | – | – | – | Release ↗ | |
| Before open | Q2 FY2023 | $6.25M | – | – | – | -$0.16 | – | Release ↗ |
Times are as filed with the SEC (before 9:30 a.m. or after 4 p.m. Eastern). See each company's Earnings tab for its full history and guidance, or the dividend calendar. Market caps as of the close on Nov 4, 2026.